A Growth Hormone
Secretropin has been approved by Health Canada for sale in Canada, and has been awarded an NPN # 80047690.
Secretropin®, the logical first step in GH therapy.
Secretropin® has been a physician only dispensed product for the past 13 years due to it's clinically documented ability to increase the production of Growth Hormone (GH) and it's growth factors (IGF-1 and IGFBP-3) by up to 650%. This was accomplished with over 1000 patient months worth of blood testing and not just 16 patients as other products tout.
Secretropin® achieves this ability through a number of established neurohormonal and nutritional pathways thereby acknowledging its Secretagogue status. A secretagogue, in regards to GH, through these pathways increases its production and release. Since Secretropin works within the body's hormonal regulatory system, over stimulation of GH production can actually lead to a drop in the measured production of GH, IGF-1 and BP-3. Just by lowering the dose of Secretropin the suppression can be reversed and the levels can increase.
In the past, many individuals were using Secretropin® to maintain their own pituitary production of GH while using injectable GH (rhGH). Science has documented the drastic reduction in our own GH production (intrinsic) when injectable (extrinsic) rhGH was used. This recovery of pituitary GH production can take up to a year if not longer. The use of Secretropin® does not cause this if used as directed under the guidance and care of a knowledgeable physician.
Starting in 2001, Secretropin(SRx), a non-peptide, secretagogue that has clinically been found to increase the production and release of GH (as measured by IGF-1 and IGFBP-3) through a number of neurochemical pathways; suppresses Somatostatin, stimulates production of GHRH, agonistic to Dopanergic and Gherlin receptors, and the non-specific Synthetic GH Receptors. Additionally, Secretropin is believed to directly stimulate pituitary Somatrophs thereby increasing the production and release of GH. Secretropin is classified as a natural food (dietary) supplement and not a drug. Secretropin does not contain any (prescription) drugs.
Presently, there are nearly 2000 physicians worldwide using Secretropin as a first approach to growth hormone, IGF-1, and IGFBP-3 enhancement. 1,020,000 doses of Secretropin were dispensed in 2013
It is a safe and cost effective means of increasing IGF-1. This is why many of our leading hormone specialists are starting with Secretropin and not leaving. Ask your physician for Secretropin before injectable. A practical solution for important results.
Unfortunately, there are many healthcare providers who have not learned about the benefits of growth hormone or other important hormones that decrease as we age and for cause (head trauma, medication, irradiation and toxins in our environment). But it is understood that by maintaining healthy physiologic levels of all hormones it is associated with quality living and health.
If you are looking to obtain Secretropin® please download the 2009 Clinical Study on Secretropin® and present it to your healthcare provider. If they still will not provide you with a prescription to purchase Secretropin®, email us your contact information and we will find a physician for you. Remember you must have blood work done prior to receiving Secretropin®. If you already have had laboratory testing for IGF-1 and IGFBP-3, we can help.
Product Label Information
We deal exclusively with Canadian Doctors, Health Professionals, Pharmacies and their Patients.
For International Orders, Research Papers and Media information, please contact us directly at email@example.com
Secretropin®, the logical "first step" in Growth Hormone treatment.
Secretropin® is registered in the United States.
Secretropin Canada is the exclusive master distributor in Canada.
NPN # 80047690
Dr. George Traitses
2914 Sheppard Ave. East, Suite 206 ,
Scarborough, Ont., Canada, M1T 3J4
416 499 5656,
Toll Free: 1 866 499 5656
Fax: 416 499 5797 or
905 201 6811.